• leader board size
Consumer Research2020-11-05T23:41:25-08:00

Consumer Research

AtaiBeckley Reports Q4 and FY 2025 Financial Results

NEW YORK – AtaiBeckley Inc. disclosed its fourth-quarter and full-year 2025 financial results, showing a significant net loss driven by costs from its recent merger while highlighting progress in its clinical programs for depression and ...

Ohio Hits Over $3B in Total Cannabis Sales

COLUMBUS – Ohio's legal Cannabis market has generated $3.56 billion in combined medical and recreational sales through the end of February, driven by steady growth in both segments since adult-use purchases became legal in August ...

LEEF Brands Reports Q4 and FY 2025 Financial Results

VANCOUVER – LEEF Brands Inc. released its fourth-quarter and full-year 2025 financial results, showing the first clear effects of its shift to in-house cultivation at the Salisbury Canyon Ranch in California. In an industry still ...

Tilray Expands Medical Cannabis Portfolio in Portugal

LOS ANGELES- Tilray Brands, Inc.  has announced a new achievement in its European medical cannabis operations. The company received approval for its new product, Tilray Solução Oral THC10, in Portugal. This follows earlier approvals for ...

Curaleaf Earnings Estimates Lowered

LOS ANGELES- Analysts at Atb Cap Markets have revised their Q2 2024 earnings estimates for Curaleaf Holdings, Inc. now forecasting a loss of $0.04 per share, down from a previous estimate of $0.03 per share. ...

Aurora Cannabis Reports Quarterly Earnings

LOS ANGELES- Aurora Cannabis Inc. reported its quarterly earnings on Thursday, June 20th, surprising analysts with a positive earnings per share (EPS) of $0.11. This result significantly surpassed the consensus estimate of a $0.18 loss ...

Medical Cannabis: Growth and Investment in 2024

LOS ANGELES- The medical cannabis industry is navigating 2024 with key players like Grow Group and Somai Pharmaceuticals leveraging new regulations and market dynamics to achieve ambitious growth targets. This article examines the recent developments ...

Constellation Brands: Analysts Maintain Ratings

LOS ANGELES- On Monday, Argus reaffirmed its Buy rating on shares of Constellation Brands (NYSE: STZ), maintaining a price target of $306.00. Argus notes the stock's value, currently trading at 18 times the firm's fiscal ...

Subscribe To Our Newsletter

Go to Top